Combining Optical Approaches with Human Inducible Pluripotent Stem Cells in G Protein-Coupled Receptor Drug Screening and Development
Drug discovery for G protein-coupled receptors (GPCRs) stands at an interesting juncture. Screening programs are slowly moving away from model heterologous cell systems such as human embryonic kidney (HEK) 293 cells to more relevant cellular, tissue and whole animal platforms. Investigators are now...
Main Authors: | Kyla Bourque, Jace Jones-Tabah, Nourhen Mnasri, Ryan D. Martin, Terence E. Hébert |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/8/4/180 |
Similar Items
-
Concise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem Cells
by: Youssef Hibaoui, et al.
Published: (2015-04-01) -
Development and validation of a simplified method to generate human microglia from pluripotent stem cells
by: Amanda McQuade, et al.
Published: (2018-12-01) -
Pluripotent Stem Cells for Disease Modeling and DrugDiscovery in Niemann-Pick Type C1
by: Christin Völkner, et al.
Published: (2021-01-01) -
Hypoxia as a Driving Force of Pluripotent Stem Cell Reprogramming and Differentiation to Endothelial Cells
by: Paulina Podkalicka, et al.
Published: (2020-11-01) -
Induced pluripotent stem cells in research and therapy of diseases: review article
by: Mohammad Reza Noori Daloii, et al.
Published: (2014-10-01)